+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Short Bowel Syndrome Market by Treatment Type, Product Type, Route of Administration, Distribution Channel, End Use, Patient Age, Etiology - Global Forecast to 2030- Product Image
Short Bowel Syndrome Market by Treatment Type, Product Type, Route of Administration, Distribution Channel, End Use, Patient Age, Etiology - Global Forecast to 2030- Product Image
Sale

Short Bowel Syndrome Market by Treatment Type, Product Type, Route of Administration, Distribution Channel, End Use, Patient Age, Etiology - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011692
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rapid expansion of the Short Bowel Syndrome Market, with an expected growth from USD 1.16 billion in 2025 to USD 2.79 billion by 2030, underscores the dynamic changes in treatment approaches and market opportunities.

Navigating Short Bowel Syndrome Treatment

Short bowel syndrome presents a multifaceted clinical challenge involving inadequate nutrient absorption due to extensive resection of the intestines. Innovations in this field, such as integrated care models, have improved patient outcomes and driven market growth. With the rising prevalence of the syndrome linked to conditions like necrotizing enterocolitis in neonates and mesenteric ischemia in adults, there is a growing demand for personalized treatment protocols. The evolution of surgical techniques and novel pharmacological options offers hope and new avenues for treatment.

Key Innovations and Clinical Progress

Emerging pharmacological agents that simulate hormonal activity have transformed the clinical landscape by enhancing intestinal adaptation. As treatments become more personalized, the integration of biomarkers helps guide treatment decisions. Technological advancements in enteral nutrition and minimally invasive surgical approaches are reshaping patient care, allowing for reduced dependency on parenteral nutrition.

Impact of 2025 U.S. Tariffs

The 2025 U.S. tariffs on imported medical components have affected supply chains, intensifying production costs. In response, manufacturers are adapting through regional sourcing and exploring vertical integration. These strategies not only address tariff challenges but also strengthen supply chain resilience and competitive positioning.

Key Takeaways from This Report

  • Highlights the dynamic growth trajectory of the Short Bowel Syndrome Market.
  • Provides insights into personalized treatment advancements driving market innovation.
  • Elucidates the impact of geopolitical factors like tariffs on market dynamics and strategies for mitigation.
  • Presents a comprehensive analysis of market segmentation, uncovering strategic opportunities for stakeholders.
  • Regional insights offer practical strategies for market entry and competitive positioning.

Unpacking Market Segmentation

Deep analysis of market segmentation reveals substantial opportunities across various treatment modalities, such as oral supplementation and parenteral nutrition, which remain core necessities for patients. Surgical interventions provide life-saving options for those with severe cases, emphasizing the role of innovative therapies in meeting diverse patient needs.

Regional Dynamics

In the United States and Canada, research and specialized care centers are advancing rapid adoption of innovative treatments. In contrast, Europe's healthcare systems are leading in trial activities, while Asia-Pacific's expanding markets are driven by increasing healthcare investments. These regional trends highlight the importance of targeted strategies to maximize market potential.

Competitive Strategies and Future Outlook

Companies are securing competitive advantages through product diversification, strategic partnerships, and investments in digital health solutions. By fostering relationships with academic institutions and leveraging real-world evidence, stakeholders are well-positioned to capitalize on emerging opportunities and streamline operational efficiencies.

Strategic Imperatives for Growth

Future success lies in the integration of patient-focused innovations, such as digital monitoring tools, and strategic partnerships with payers for outcome-based reimbursement models. By aligning R&D initiatives with demographic insights, companies can address unmet genetic and pediatric needs, thus solidifying their market presence.

Rigorous Research Methodology

Built on a robust research framework, this report synthesizes insights from primary and secondary sources, ensuring comprehensive analysis of market dynamics and future trends. Engaging key opinion leaders and stakeholders enhances the validity of treatment forecasts and operational challenges identified.

Synthesis and Conclusion

The shifting landscape of the Short Bowel Syndrome Market, driven by innovation and external influences like tariffs, demands agile strategies. By focusing on integrated care and evidence-based collaborations, stakeholders can enhance patient outcomes and sustain growth, thus reaffirming the critical role of collaboration in healthcare advancements.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Short Bowel Syndrome Market, by Treatment Type
8.1. Introduction
8.2. Oral Supplementation
8.2.1. Dietary Supplements
8.2.2. Nutritional Formulas
8.3. Parenteral Nutrition
8.3.1. Customized Pn
8.3.2. Standard Pn
8.4. Pharmacological Therapy
8.4.1. Antibiotics
8.4.2. Growth Factors
8.4.3. Hormonal Agents
8.5. Surgical Intervention
8.5.1. Bowel Transplantation
8.5.2. Intestinal Lengthening Procedures
9. Short Bowel Syndrome Market, by Product Type
9.1. Introduction
9.2. Adjunctive Therapies
9.2.1. Probiotics
9.2.2. Vitamins and Minerals
9.3. Enteral Formulas
9.3.1. Elemental Formulas
9.3.2. Polymeric Formulas
9.3.3. Semi-elemental Formulas
9.4. Pharmacologics
9.4.1. Teduglutide
9.5. Pn Solutions
9.5.1. Amino Acid Solutions
9.5.2. Carbohydrate Solutions
9.5.3. Lipid Emulsions
10. Short Bowel Syndrome Market, by Route of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Short Bowel Syndrome Market, by Distribution Channel
11.1. Introduction
11.2. Home Healthcare
11.3. Hospital Pharmacy
11.4. Online Pharmacies
11.5. Retail Pharmacy
12. Short Bowel Syndrome Market, by End Use
12.1. Introduction
12.2. Home Care Facilities
12.3. Hospitals
12.4. Specialty Clinics
13. Short Bowel Syndrome Market, by Patient Age
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Short Bowel Syndrome Market, by Etiology
14.1. Introduction
14.2. Congenital Conditions
14.3. Crohn Disease
14.4. Mesenteric Ischemia
15. Americas Short Bowel Syndrome Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Short Bowel Syndrome Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Short Bowel Syndrome Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Baxter International, Inc.
18.3.2. Danone S.A.
18.3.3. Nestlé S.A.
18.3.4. Abbott Laboratories
18.3.5. Fresenius Kabi AG
18.3.6. B. Braun Melsungen AG
18.3.7. Pfizer Inc.
18.3.8. Takeda Pharmaceutical Company Limited
18.3.9. Cardinal Health, Inc.
18.3.10. McKesson Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SHORT BOWEL SYNDROME MARKET MULTI-CURRENCY
FIGURE 2. SHORT BOWEL SYNDROME MARKET MULTI-LANGUAGE
FIGURE 3. SHORT BOWEL SYNDROME MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SHORT BOWEL SYNDROME MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SHORT BOWEL SYNDROME MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SHORT BOWEL SYNDROME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY NUTRITIONAL FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CUSTOMIZED PN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY STANDARD PN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY BOWEL TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTESTINAL LENGTHENING PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY VITAMINS AND MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ELEMENTAL FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY POLYMERIC FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SEMI-ELEMENTAL FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TEDUGLUTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY AMINO ACID SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CARBOHYDRATE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY LIPID EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CONGENITAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CROHN DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY MESENTERIC ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 94. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 97. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 98. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 99. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 101. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 102. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 103. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 104. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 107. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 108. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 185. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 188. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 189. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 190. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 192. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 198. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 199. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 200. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 202. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 204. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 207. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 213. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 214. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 230. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 232. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 233. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 234. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 235. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 237. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 238. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 239. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 240. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 243. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 244. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 245. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 249. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 250. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 252. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 253. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 255. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 258. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 259. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 306. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 307. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 308. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 309. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 310. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 312. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2030 (USD MILLION)
TABLE 313. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2030 (USD MILLION)
TABLE 314. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 315. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 318. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 319. DENMARK SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 325. NETHERLA

Companies Mentioned

The companies profiled in this Short Bowel Syndrome market report include:
  • Baxter International, Inc.
  • Danone S.A.
  • Nestlé S.A.
  • Abbott Laboratories
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Cardinal Health, Inc.
  • McKesson Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.79 Billion
Compound Annual Growth Rate19.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Short Bowel Syndrome (SBS) - Global Strategic Business Report - Product Image

Short Bowel Syndrome (SBS) - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Short Bowel Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Short Bowel Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market by Indication, Drug Class, Route of Administration, Distribution Channel, Dosage Form, End User - Global Forecast to 2030 - Product Image

Gastrointestinal Diseases Therapeutics Market by Indication, Drug Class, Route of Administration, Distribution Channel, Dosage Form, End User - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Short Bowel Syndrome - Epidemiology Forecast - 2034 - Product Image

Short Bowel Syndrome - Epidemiology Forecast - 2034

  • Report
  • 66 Pages
  • Global
From
Cimetropium bromide Market by Indication, Distribution Channel, Route of Administration, Formulation, End User, Dosage Strength - Global Forecast to 2030 - Product Image

Cimetropium bromide Market by Indication, Distribution Channel, Route of Administration, Formulation, End User, Dosage Strength - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From

About the Short Bowel Syndrome Drug Market

Short Bowel Syndrome (SBS) is a rare disorder that affects the small intestine, resulting in malabsorption of nutrients and fluids. It is typically caused by the surgical removal of a large portion of the small intestine, or by a congenital defect. Treatment for SBS typically involves the use of specialized drugs to help the body absorb nutrients and fluids, as well as to reduce the risk of infection. The SBS drug market is a subset of the larger gastrointestinal drug market, which includes drugs used to treat a variety of gastrointestinal disorders. The SBS drug market is relatively small, but is expected to grow in the coming years due to increasing awareness of the disorder and the development of new treatments. Some of the major companies in the SBS drug market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.